Results 61 to 70 of about 1,279 (113)

Controversies in neuroimmunology: multiple sclerosis, vaccination, SARS-CoV-2 and other dilemas [PDF]

Biomedica, 2022
Reyes-Niño S, Rodríguez-Orozco JE, Moutran-Barroso HG, Kreinter-Rosembaun H, Gaviria-Carrillo M, Salej-Durán V, Mancera-Charry J, Villegas AC, Cuellar-Giraldo D, Torres-Sandoval JS, Gómez-Mazuera Á, Duque-Samper A, Toro-Gómez J.   +12 more
europepmc   +1 more source

ePosters

European Journal of Neurology, Volume 31, Issue S1, June 2024.
wiley   +1 more source

COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study. [PDF]

Med Clin (Engl Ed), 2023
Rahmani M, Moghadasi AN, Shahi S, Eskandarieh S, Azizi H, Hasanzadeh A, Ahmadzade A, Dehnavi AZ, Farahani RH, Aminianfar M, Naeini AR.   +10 more
europepmc   +2 more sources

ePosters Virtual

European Journal of Neurology, Volume 31, Issue S1, June 2024.
wiley   +1 more source

Focused Workshops

European Journal of Neurology, Volume 31, Issue S1, June 2024.
wiley   +1 more source

Primoinfección por citomegalovirus en un paciente con esclerosis múltiple recurrente-remitente tratado con alemtuzumab

Neurología, 2020
S. Eichau, R. López Ruiz, J.J. Castón Osorio, E. Ramírez, A. Domínguez-Mayoral, G. Izquierdo   +5 more
doaj   +1 more source

Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors

BMC Neurology
Background Effective interventions for Multiple Sclerosis require timely treatment optimization which usually involves switching disease modifying therapies.
Simón Cárdenas-Robledo, Laura Estefanía Arenas-Vargas, Rubén Darío Arenas, Jorge Mario Gaspar-Toro, Ángela María Muñoz-Rosero, Aranza Helena Tafur-Borrero, Daniel Stiven Marín-Medina, Hernan Andrés Acosta-Fajardo, Claudia Guío-Sánchez, Lorena López-Reyes   +9 more
doaj   +1 more source

Factors associated with time to disability progression in patients with multiple sclerosis. [PDF]

Rev Peru Med Exp Salud Publica, 2022
Arteaga-Noriega A, Castro-Álvarez JF, Benjumea-Bedoya D, Gutiérrez-Vargas J, Segura-Cardona A, González-Gómez D, Zapata-Berruecos J.   +6 more
europepmc   +1 more source

[Usefulness of the kappa index in the diagnosis of multiple sclerosis and validation of reference values in the Community of Aragon]. [PDF]

Rev Neurol, 2022
Saldaña-Inda I, Aparicio-Pelaz D, Rodríguez-Montolio J, Sebastián-Torres B, Iñíguez-Martínez C, Inda-Landaluce M.   +5 more
europepmc   +1 more source

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Frontiers in Immunology
BackgroundSerum biomarkers as neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) enabled early identification of multiple sclerosis (MS) patients at risk of relapse-associated worsening (RAW) or progression independent of ...
Alexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, Raquel Sainz-Amo, Roberto Álvarez-Lafuente, Manuel Comabella, Manuel Comabella, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, José M. García-Domínguez, Noelia Villarrubia, Susana Sainz de la Maza, María Domínguez-Mozo, Ana Quiroga-Varela, Juan Luís Chico-García, Fernando Rodriguez-Jorge, José Luis Veiga-Gonzalez, Ernesto Roldán-Santiago, Mercedes Espiño, Eulalia Rodríguez-Martín, Gary Álvarez, Jaime Masjuan, Xavier Montalban, Xavier Montalban, Lucienne Costa-Frossard, Luisa María Villar   +26 more
doaj   +1 more source